aluates Reports

$ 0.0

Automative

Global Irritable Bowel Syndrome Treatment Drug Market Research Report 2025

Published Date: May 2025

Report Code: QYRE-Auto-15R13960

Global Irritable Bowel Syndrome Treatment Drug Market Research Report 2023

BUY CHAPTERS

Global Irritable Bowel Syndrome Treatment Drug Market Research Report 2025

Code: QYRE-Auto-15R13960

Report

May 2025

Pages:79

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

AbbVie

Bristol–Myers Squibb

Roche

Johnson & Johnson

Pfizer Inc

Prometheus Laboratories Inc. (Nestle)

Bausch Health

Takeda Pharmaceutical Ltd

Biogen

Astrazeneca plc

Irritable Bowel Syndrome Treatment Drug Market Size

The global market for Irritable Bowel Syndrome Treatment Drug was valued at US$ 3722 million in the year 2024 and is projected to reach a revised size of US$ 4595 million by 2031, growing at a CAGR of 3.1% during the forecast period.

Irritable Bowel Syndrome Treatment Drug Market

Irritable bowel syndrome (IBS) is a common condition that affects the digestive system. It causes symptoms like stomach cramps, bloating, diarrhoea and constipation. These tend to come and go over time, and can last for days, weeks or months at a time. It"s usually a lifelong problem.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Irritable Bowel Syndrome Treatment Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Irritable Bowel Syndrome Treatment Drug.

The Irritable Bowel Syndrome Treatment Drug market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Irritable Bowel Syndrome Treatment Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Irritable Bowel Syndrome Treatment Drug companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Irritable Bowel Syndrome Treatment Drug Market Report

Report Metric	Details
Report Name	Irritable Bowel Syndrome Treatment Drug Market
Accounted market size in year	US$ 3722 million
Forecasted market size in 2031	US$ 4595 million
CAGR	3.1%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Antibiotics Amino Salicylates Corticosteroids Immunomodulators Others
Segment by Application	Hospitals Specialty Clinics Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Abbvie Inc., Bristol Myers Squibb, Roche, Johnson & Johnson, Pfizer Inc., Prometheus Laboratories Inc. (Nestle), Bausch Health, Takeda Pharmaceutical Ltd, Biogen, AstraZeneca
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Irritable Bowel Syndrome Treatment Drug company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Irritable Bowel Syndrome Treatment Drug Market growing?

Ans: The Irritable Bowel Syndrome Treatment Drug Market witnessing a CAGR of 3.1% during the forecast period 2025-2031.

What is the Irritable Bowel Syndrome Treatment Drug Market size in 2031?

Ans: The Irritable Bowel Syndrome Treatment Drug Market size in 2031 will be US$ 4595 million.

Who are the main players in the Irritable Bowel Syndrome Treatment Drug Market report?

Ans: The main players in the Irritable Bowel Syndrome Treatment Drug Market are Abbvie Inc., Bristol Myers Squibb, Roche, Johnson & Johnson, Pfizer Inc., Prometheus Laboratories Inc. (Nestle), Bausch Health, Takeda Pharmaceutical Ltd, Biogen, AstraZeneca

What are the Application segmentation covered in the Irritable Bowel Syndrome Treatment Drug Market report?

Ans: The Applications covered in the Irritable Bowel Syndrome Treatment Drug Market report are Hospitals, Specialty Clinics, Other

What are the Type segmentation covered in the Irritable Bowel Syndrome Treatment Drug Market report?

Ans: The Types covered in the Irritable Bowel Syndrome Treatment Drug Market report are Antibiotics, Amino Salicylates, Corticosteroids, Immunomodulators, Others

Recommended Reports

Digestive Disorder Drugs

Gastrointestinal Treatments

Pain & Nervous Disorders

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Irritable Bowel Syndrome Treatment Drug Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Antibiotics

1.2.3 Amino Salicylates

1.2.4 Corticosteroids

1.2.5 Immunomodulators

1.2.6 Others

1.3 Market by Application

1.3.1 Global Irritable Bowel Syndrome Treatment Drug Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospitals

1.3.3 Specialty Clinics

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Irritable Bowel Syndrome Treatment Drug Market Perspective (2020-2031)

2.2 Global Irritable Bowel Syndrome Treatment Drug Growth Trends by Region

2.2.1 Global Irritable Bowel Syndrome Treatment Drug Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Irritable Bowel Syndrome Treatment Drug Historic Market Size by Region (2020-2025)

2.2.3 Irritable Bowel Syndrome Treatment Drug Forecasted Market Size by Region (2026-2031)

2.3 Irritable Bowel Syndrome Treatment Drug Market Dynamics

2.3.1 Irritable Bowel Syndrome Treatment Drug Industry Trends

2.3.2 Irritable Bowel Syndrome Treatment Drug Market Drivers

2.3.3 Irritable Bowel Syndrome Treatment Drug Market Challenges

2.3.4 Irritable Bowel Syndrome Treatment Drug Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Irritable Bowel Syndrome Treatment Drug Players by Revenue

3.1.1 Global Top Irritable Bowel Syndrome Treatment Drug Players by Revenue (2020-2025)

3.1.2 Global Irritable Bowel Syndrome Treatment Drug Revenue Market Share by Players (2020-2025)

3.2 Global Irritable Bowel Syndrome Treatment Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Irritable Bowel Syndrome Treatment Drug Revenue

3.4 Global Irritable Bowel Syndrome Treatment Drug Market Concentration Ratio

3.4.1 Global Irritable Bowel Syndrome Treatment Drug Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Irritable Bowel Syndrome Treatment Drug Revenue in 2024

3.5 Global Key Players of Irritable Bowel Syndrome Treatment Drug Head office and Area Served

3.6 Global Key Players of Irritable Bowel Syndrome Treatment Drug, Product and Application

3.7 Global Key Players of Irritable Bowel Syndrome Treatment Drug, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Irritable Bowel Syndrome Treatment Drug Breakdown Data by Type

4.1 Global Irritable Bowel Syndrome Treatment Drug Historic Market Size by Type (2020-2025)

4.2 Global Irritable Bowel Syndrome Treatment Drug Forecasted Market Size by Type (2026-2031)

5 Irritable Bowel Syndrome Treatment Drug Breakdown Data by Application

5.1 Global Irritable Bowel Syndrome Treatment Drug Historic Market Size by Application (2020-2025)

5.2 Global Irritable Bowel Syndrome Treatment Drug Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Irritable Bowel Syndrome Treatment Drug Market Size (2020-2031)

6.2 North America Irritable Bowel Syndrome Treatment Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Irritable Bowel Syndrome Treatment Drug Market Size by Country (2020-2025)

6.4 North America Irritable Bowel Syndrome Treatment Drug Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Irritable Bowel Syndrome Treatment Drug Market Size (2020-2031)

7.2 Europe Irritable Bowel Syndrome Treatment Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Irritable Bowel Syndrome Treatment Drug Market Size by Country (2020-2025)

7.4 Europe Irritable Bowel Syndrome Treatment Drug Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Irritable Bowel Syndrome Treatment Drug Market Size (2020-2031)

8.2 Asia-Pacific Irritable Bowel Syndrome Treatment Drug Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Irritable Bowel Syndrome Treatment Drug Market Size by Region (2020-2025)

8.4 Asia-Pacific Irritable Bowel Syndrome Treatment Drug Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Irritable Bowel Syndrome Treatment Drug Market Size (2020-2031)

9.2 Latin America Irritable Bowel Syndrome Treatment Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Irritable Bowel Syndrome Treatment Drug Market Size by Country (2020-2025)

9.4 Latin America Irritable Bowel Syndrome Treatment Drug Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Irritable Bowel Syndrome Treatment Drug Market Size (2020-2031)

10.2 Middle East & Africa Irritable Bowel Syndrome Treatment Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Irritable Bowel Syndrome Treatment Drug Market Size by Country (2020-2025)

10.4 Middle East & Africa Irritable Bowel Syndrome Treatment Drug Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Abbvie Inc.

11.1.1 Abbvie Inc. Company Details

11.1.2 Abbvie Inc. Business Overview

11.1.3 Abbvie Inc. Irritable Bowel Syndrome Treatment Drug Introduction

11.1.4 Abbvie Inc. Revenue in Irritable Bowel Syndrome Treatment Drug Business (2020-2025)

11.1.5 Abbvie Inc. Recent Development

11.2 Bristol Myers Squibb

11.2.1 Bristol Myers Squibb Company Details

11.2.2 Bristol Myers Squibb Business Overview

11.2.3 Bristol Myers Squibb Irritable Bowel Syndrome Treatment Drug Introduction

11.2.4 Bristol Myers Squibb Revenue in Irritable Bowel Syndrome Treatment Drug Business (2020-2025)

11.2.5 Bristol Myers Squibb Recent Development

11.3 Roche

11.3.1 Roche Company Details

11.3.2 Roche Business Overview

11.3.3 Roche Irritable Bowel Syndrome Treatment Drug Introduction

11.3.4 Roche Revenue in Irritable Bowel Syndrome Treatment Drug Business (2020-2025)

11.3.5 Roche Recent Development

11.4 Johnson & Johnson

11.4.1 Johnson & Johnson Company Details

11.4.2 Johnson & Johnson Business Overview

11.4.3 Johnson & Johnson Irritable Bowel Syndrome Treatment Drug Introduction

11.4.4 Johnson & Johnson Revenue in Irritable Bowel Syndrome Treatment Drug Business (2020-2025)

11.4.5 Johnson & Johnson Recent Development

11.5 Pfizer Inc.

11.5.1 Pfizer Inc. Company Details

11.5.2 Pfizer Inc. Business Overview

11.5.3 Pfizer Inc. Irritable Bowel Syndrome Treatment Drug Introduction

11.5.4 Pfizer Inc. Revenue in Irritable Bowel Syndrome Treatment Drug Business (2020-2025)

11.5.5 Pfizer Inc. Recent Development

11.6 Prometheus Laboratories Inc. (Nestle)

11.6.1 Prometheus Laboratories Inc. (Nestle) Company Details

11.6.2 Prometheus Laboratories Inc. (Nestle) Business Overview

11.6.3 Prometheus Laboratories Inc. (Nestle) Irritable Bowel Syndrome Treatment Drug Introduction

11.6.4 Prometheus Laboratories Inc. (Nestle) Revenue in Irritable Bowel Syndrome Treatment Drug Business (2020-2025)

11.6.5 Prometheus Laboratories Inc. (Nestle) Recent Development

11.7 Bausch Health

11.7.1 Bausch Health Company Details

11.7.2 Bausch Health Business Overview

11.7.3 Bausch Health Irritable Bowel Syndrome Treatment Drug Introduction

11.7.4 Bausch Health Revenue in Irritable Bowel Syndrome Treatment Drug Business (2020-2025)

11.7.5 Bausch Health Recent Development

11.8 Takeda Pharmaceutical Ltd

11.8.1 Takeda Pharmaceutical Ltd Company Details

11.8.2 Takeda Pharmaceutical Ltd Business Overview

11.8.3 Takeda Pharmaceutical Ltd Irritable Bowel Syndrome Treatment Drug Introduction

11.8.4 Takeda Pharmaceutical Ltd Revenue in Irritable Bowel Syndrome Treatment Drug Business (2020-2025)

11.8.5 Takeda Pharmaceutical Ltd Recent Development

11.9 Biogen

11.9.1 Biogen Company Details

11.9.2 Biogen Business Overview

11.9.3 Biogen Irritable Bowel Syndrome Treatment Drug Introduction

11.9.4 Biogen Revenue in Irritable Bowel Syndrome Treatment Drug Business (2020-2025)

11.9.5 Biogen Recent Development

11.10 AstraZeneca

11.10.1 AstraZeneca Company Details

11.10.2 AstraZeneca Business Overview

11.10.3 AstraZeneca Irritable Bowel Syndrome Treatment Drug Introduction

11.10.4 AstraZeneca Revenue in Irritable Bowel Syndrome Treatment Drug Business (2020-2025)

11.10.5 AstraZeneca Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

AbbVie

Bristol–Myers Squibb

Roche

Johnson & Johnson

Pfizer Inc

Prometheus Laboratories Inc. (Nestle)

Bausch Health

Takeda Pharmaceutical Ltd

Biogen

Astrazeneca plc

List of Tables

Table 1. Global Irritable Bowel Syndrome Treatment Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Antibiotics

Table 3. Key Players of Amino Salicylates

Table 4. Key Players of Corticosteroids

Table 5. Key Players of Immunomodulators

Table 6. Key Players of Others

Table 7. Global Irritable Bowel Syndrome Treatment Drug Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Irritable Bowel Syndrome Treatment Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 9. Global Irritable Bowel Syndrome Treatment Drug Market Size by Region (2020-2025) & (US$ Million)

Table 10. Global Irritable Bowel Syndrome Treatment Drug Market Share by Region (2020-2025)

Table 11. Global Irritable Bowel Syndrome Treatment Drug Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 12. Global Irritable Bowel Syndrome Treatment Drug Market Share by Region (2026-2031)

Table 13. Irritable Bowel Syndrome Treatment Drug Market Trends

Table 14. Irritable Bowel Syndrome Treatment Drug Market Drivers

Table 15. Irritable Bowel Syndrome Treatment Drug Market Challenges

Table 16. Irritable Bowel Syndrome Treatment Drug Market Restraints

Table 17. Global Irritable Bowel Syndrome Treatment Drug Revenue by Players (2020-2025) & (US$ Million)

Table 18. Global Irritable Bowel Syndrome Treatment Drug Market Share by Players (2020-2025)

Table 19. Global Top Irritable Bowel Syndrome Treatment Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Irritable Bowel Syndrome Treatment Drug as of 2024)

Table 20. Ranking of Global Top Irritable Bowel Syndrome Treatment Drug Companies by Revenue (US$ Million) in 2024

Table 21. Global 5 Largest Players Market Share by Irritable Bowel Syndrome Treatment Drug Revenue (CR5 and HHI) & (2020-2025)

Table 22. Global Key Players of Irritable Bowel Syndrome Treatment Drug, Headquarters and Area Served

Table 23. Global Key Players of Irritable Bowel Syndrome Treatment Drug, Product and Application

Table 24. Global Key Players of Irritable Bowel Syndrome Treatment Drug, Date of Enter into This Industry

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Irritable Bowel Syndrome Treatment Drug Market Size by Type (2020-2025) & (US$ Million)

Table 27. Global Irritable Bowel Syndrome Treatment Drug Revenue Market Share by Type (2020-2025)

Table 28. Global Irritable Bowel Syndrome Treatment Drug Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 29. Global Irritable Bowel Syndrome Treatment Drug Revenue Market Share by Type (2026-2031)

Table 30. Global Irritable Bowel Syndrome Treatment Drug Market Size by Application (2020-2025) & (US$ Million)

Table 31. Global Irritable Bowel Syndrome Treatment Drug Revenue Market Share by Application (2020-2025)

Table 32. Global Irritable Bowel Syndrome Treatment Drug Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 33. Global Irritable Bowel Syndrome Treatment Drug Revenue Market Share by Application (2026-2031)

Table 34. North America Irritable Bowel Syndrome Treatment Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. North America Irritable Bowel Syndrome Treatment Drug Market Size by Country (2020-2025) & (US$ Million)

Table 36. North America Irritable Bowel Syndrome Treatment Drug Market Size by Country (2026-2031) & (US$ Million)

Table 37. Europe Irritable Bowel Syndrome Treatment Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 38. Europe Irritable Bowel Syndrome Treatment Drug Market Size by Country (2020-2025) & (US$ Million)

Table 39. Europe Irritable Bowel Syndrome Treatment Drug Market Size by Country (2026-2031) & (US$ Million)

Table 40. Asia-Pacific Irritable Bowel Syndrome Treatment Drug Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 41. Asia-Pacific Irritable Bowel Syndrome Treatment Drug Market Size by Region (2020-2025) & (US$ Million)

Table 42. Asia-Pacific Irritable Bowel Syndrome Treatment Drug Market Size by Region (2026-2031) & (US$ Million)

Table 43. Latin America Irritable Bowel Syndrome Treatment Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Latin America Irritable Bowel Syndrome Treatment Drug Market Size by Country (2020-2025) & (US$ Million)

Table 45. Latin America Irritable Bowel Syndrome Treatment Drug Market Size by Country (2026-2031) & (US$ Million)

Table 46. Middle East & Africa Irritable Bowel Syndrome Treatment Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 47. Middle East & Africa Irritable Bowel Syndrome Treatment Drug Market Size by Country (2020-2025) & (US$ Million)

Table 48. Middle East & Africa Irritable Bowel Syndrome Treatment Drug Market Size by Country (2026-2031) & (US$ Million)

Table 49. Abbvie Inc. Company Details

Table 50. Abbvie Inc. Business Overview

Table 51. Abbvie Inc. Irritable Bowel Syndrome Treatment Drug Product

Table 52. Abbvie Inc. Revenue in Irritable Bowel Syndrome Treatment Drug Business (2020-2025) & (US$ Million)

Table 53. Abbvie Inc. Recent Development

Table 54. Bristol Myers Squibb Company Details

Table 55. Bristol Myers Squibb Business Overview

Table 56. Bristol Myers Squibb Irritable Bowel Syndrome Treatment Drug Product

Table 57. Bristol Myers Squibb Revenue in Irritable Bowel Syndrome Treatment Drug Business (2020-2025) & (US$ Million)

Table 58. Bristol Myers Squibb Recent Development

Table 59. Roche Company Details

Table 60. Roche Business Overview

Table 61. Roche Irritable Bowel Syndrome Treatment Drug Product

Table 62. Roche Revenue in Irritable Bowel Syndrome Treatment Drug Business (2020-2025) & (US$ Million)

Table 63. Roche Recent Development

Table 64. Johnson & Johnson Company Details

Table 65. Johnson & Johnson Business Overview

Table 66. Johnson & Johnson Irritable Bowel Syndrome Treatment Drug Product

Table 67. Johnson & Johnson Revenue in Irritable Bowel Syndrome Treatment Drug Business (2020-2025) & (US$ Million)

Table 68. Johnson & Johnson Recent Development

Table 69. Pfizer Inc. Company Details

Table 70. Pfizer Inc. Business Overview

Table 71. Pfizer Inc. Irritable Bowel Syndrome Treatment Drug Product

Table 72. Pfizer Inc. Revenue in Irritable Bowel Syndrome Treatment Drug Business (2020-2025) & (US$ Million)

Table 73. Pfizer Inc. Recent Development

Table 74. Prometheus Laboratories Inc. (Nestle) Company Details

Table 75. Prometheus Laboratories Inc. (Nestle) Business Overview

Table 76. Prometheus Laboratories Inc. (Nestle) Irritable Bowel Syndrome Treatment Drug Product

Table 77. Prometheus Laboratories Inc. (Nestle) Revenue in Irritable Bowel Syndrome Treatment Drug Business (2020-2025) & (US$ Million)

Table 78. Prometheus Laboratories Inc. (Nestle) Recent Development

Table 79. Bausch Health Company Details

Table 80. Bausch Health Business Overview

Table 81. Bausch Health Irritable Bowel Syndrome Treatment Drug Product

Table 82. Bausch Health Revenue in Irritable Bowel Syndrome Treatment Drug Business (2020-2025) & (US$ Million)

Table 83. Bausch Health Recent Development

Table 84. Takeda Pharmaceutical Ltd Company Details

Table 85. Takeda Pharmaceutical Ltd Business Overview

Table 86. Takeda Pharmaceutical Ltd Irritable Bowel Syndrome Treatment Drug Product

Table 87. Takeda Pharmaceutical Ltd Revenue in Irritable Bowel Syndrome Treatment Drug Business (2020-2025) & (US$ Million)

Table 88. Takeda Pharmaceutical Ltd Recent Development

Table 89. Biogen Company Details

Table 90. Biogen Business Overview

Table 91. Biogen Irritable Bowel Syndrome Treatment Drug Product

Table 92. Biogen Revenue in Irritable Bowel Syndrome Treatment Drug Business (2020-2025) & (US$ Million)

Table 93. Biogen Recent Development

Table 94. AstraZeneca Company Details

Table 95. AstraZeneca Business Overview

Table 96. AstraZeneca Irritable Bowel Syndrome Treatment Drug Product

Table 97. AstraZeneca Revenue in Irritable Bowel Syndrome Treatment Drug Business (2020-2025) & (US$ Million)

Table 98. AstraZeneca Recent Development

Table 99. Research Programs/Design for This Report

Table 100. Key Data Information from Secondary Sources

Table 101. Key Data Information from Primary Sources

Table 102. Authors List of This Report

List of Figures

Figure 1. Irritable Bowel Syndrome Treatment Drug Picture

Figure 2. Global Irritable Bowel Syndrome Treatment Drug Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Irritable Bowel Syndrome Treatment Drug Market Share by Type: 2024 VS 2031

Figure 4. Antibiotics Features

Figure 5. Amino Salicylates Features

Figure 6. Corticosteroids Features

Figure 7. Immunomodulators Features

Figure 8. Others Features

Figure 9. Global Irritable Bowel Syndrome Treatment Drug Market Size by Application (2020-2031) & (US$ Million)

Figure 10. Global Irritable Bowel Syndrome Treatment Drug Market Share by Application: 2024 VS 2031

Figure 11. Hospitals Case Studies

Figure 12. Specialty Clinics Case Studies

Figure 13. Other Case Studies

Figure 14. Irritable Bowel Syndrome Treatment Drug Report Years Considered

Figure 15. Global Irritable Bowel Syndrome Treatment Drug Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 16. Global Irritable Bowel Syndrome Treatment Drug Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 17. Global Irritable Bowel Syndrome Treatment Drug Market Share by Region: 2024 VS 2031

Figure 18. Global Irritable Bowel Syndrome Treatment Drug Market Share by Players in 2024

Figure 19. Global Top Irritable Bowel Syndrome Treatment Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Irritable Bowel Syndrome Treatment Drug as of 2024)

Figure 20. The Top 10 and 5 Players Market Share by Irritable Bowel Syndrome Treatment Drug Revenue in 2024

Figure 21. North America Irritable Bowel Syndrome Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. North America Irritable Bowel Syndrome Treatment Drug Market Share by Country (2020-2031)

Figure 23. United States Irritable Bowel Syndrome Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Canada Irritable Bowel Syndrome Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Irritable Bowel Syndrome Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Europe Irritable Bowel Syndrome Treatment Drug Market Share by Country (2020-2031)

Figure 27. Germany Irritable Bowel Syndrome Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. France Irritable Bowel Syndrome Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. U.K. Irritable Bowel Syndrome Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Italy Irritable Bowel Syndrome Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Russia Irritable Bowel Syndrome Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Nordic Countries Irritable Bowel Syndrome Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Irritable Bowel Syndrome Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Asia-Pacific Irritable Bowel Syndrome Treatment Drug Market Share by Region (2020-2031)

Figure 35. China Irritable Bowel Syndrome Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Japan Irritable Bowel Syndrome Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. South Korea Irritable Bowel Syndrome Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Southeast Asia Irritable Bowel Syndrome Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. India Irritable Bowel Syndrome Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Australia Irritable Bowel Syndrome Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Irritable Bowel Syndrome Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Latin America Irritable Bowel Syndrome Treatment Drug Market Share by Country (2020-2031)

Figure 43. Mexico Irritable Bowel Syndrome Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Brazil Irritable Bowel Syndrome Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Irritable Bowel Syndrome Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Middle East & Africa Irritable Bowel Syndrome Treatment Drug Market Share by Country (2020-2031)

Figure 47. Turkey Irritable Bowel Syndrome Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Saudi Arabia Irritable Bowel Syndrome Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. UAE Irritable Bowel Syndrome Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Abbvie Inc. Revenue Growth Rate in Irritable Bowel Syndrome Treatment Drug Business (2020-2025)

Figure 51. Bristol Myers Squibb Revenue Growth Rate in Irritable Bowel Syndrome Treatment Drug Business (2020-2025)

Figure 52. Roche Revenue Growth Rate in Irritable Bowel Syndrome Treatment Drug Business (2020-2025)

Figure 53. Johnson & Johnson Revenue Growth Rate in Irritable Bowel Syndrome Treatment Drug Business (2020-2025)

Figure 54. Pfizer Inc. Revenue Growth Rate in Irritable Bowel Syndrome Treatment Drug Business (2020-2025)

Figure 55. Prometheus Laboratories Inc. (Nestle) Revenue Growth Rate in Irritable Bowel Syndrome Treatment Drug Business (2020-2025)

Figure 56. Bausch Health Revenue Growth Rate in Irritable Bowel Syndrome Treatment Drug Business (2020-2025)

Figure 57. Takeda Pharmaceutical Ltd Revenue Growth Rate in Irritable Bowel Syndrome Treatment Drug Business (2020-2025)

Figure 58. Biogen Revenue Growth Rate in Irritable Bowel Syndrome Treatment Drug Business (2020-2025)

Figure 59. AstraZeneca Revenue Growth Rate in Irritable Bowel Syndrome Treatment Drug Business (2020-2025)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Irritable Bowel Syndrome with Diarrhea IBS D Drugs Market Size Manufacturers Supply Chain Sales Channel and Clients 2024 2030

Global Irritable Bowel Syndrome IBS Market Insights Forecast to 2030

Global Rx Irritable Bowel Syndrome IBS Drugs Market Insights Forecast to 2030

Irritable Bowel Syndrome IBS Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Gastrointestinal Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031

Global Gastrointestinal Therapeutics Market Research Report 2024

Global Irritable Bowel Syndrome Drug Market Research Report 2024

Global Digestive Drugs Market Insights Forecast to 2030

Global Gastrointestinal Drugs Market Research Report 2025

Global Digestive Remedies Market Research Report 2024

Global Irritable Bowel Syndrome Medication Market Research Report 2025

Global Prescription Gastrointestinal Drugs Market Research Report 2024

Global IBS Probiotic Supplement Market Research Report 2024

Global Functional Dyspepsia Drug Market Insights Forecast to 2030

Global Irritable Bowel Syndrome with Constipation Drugs Market Research Report 2024

Global Amebiasis Drugs Market Insights Forecast to 2030

Inflammatory Bowel Disease Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global OTC Digestives and Intestinal Remedies Market Research Report 2024

Global Digestive Distress Treatment Market Research Report 2024

RELATED REPORTS

Global Drug-Free Pain Management Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-33I16356

Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Adult Artificial Heart Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-32W16534

Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Viral Vector Vaccine for Humans Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-23Z16367

Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Cardioplegia Adapter Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-33A16598

Thu Sep 25 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions